Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (3) , 355-359
- https://doi.org/10.1016/s0022-3476(05)82820-3
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- PARVOVIRUS INFECTION, LEUKAEMIA, AND IMMUNODEFICIENCYThe Lancet, 1989
- HUMAN PARVOVIRUS B19 INFECTION ASSOCIATED WITH PROLONGED ERYTHROBLASTOPENIA IN A LEUKEMIC CHILDThe Pediatric Infectious Disease Journal, 1989
- PERSISTENT B19 PARVOVIRUS INFECTION AS A CAUSE OF SEVERE CHRONIC ANAEMIA IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIAThe Lancet, 1988
- Severe Anemia Caused by Human Parvovirus in a Leukemia Patient on Maintenance ChemotherapyClinical Pediatrics, 1988
- Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus InfectionNew England Journal of Medicine, 1987
- Replication of the B19 Parvovirus in Human Bone Marrow Cell CulturesScience, 1986
- Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemiaBlood, 1986
- Human Parvovirus-Associated Red Cell Aplasia in the Absence of Underlying Hemolytic AnemiaJournal of Pediatric Hematology/Oncology, 1986
- A human parvovirus-like virus inhibits haematopoietic colony formation in vitroNature, 1983